Serum keratin 18‐M65 levels detect progressive forms of alcohol‐associated liver disease in early noncirrhotic stages
Alcohol: Clinical and Experimental Research · 2023-06 · 47 (6) · 1079-1087
DOI: 10.1111/acer.15081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcohol: Clinical and Experimental Research, online erschienen am 27.04.2023. Verfasst von Luca Maccioni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Hepato-Gastroenterology, Institute of Experimental and Clinical Research, UCLouvain, Université Catholique de Louvain, Brussels, Belgiu…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, BLRD VA, NIDDK NIH HHS.
Abstract (Originalsprache)
Background and Aims The progression of alcohol‐associated liver disease (ALD) in its early precirrhotic stages can be a silent process. Serum keratin 18 levels (K18‐M65) predict severe events and mortality in advanced stages of ALD, but data on this biomarker in early stages are scarce. We evaluated the diagnostic accuracy of K18‐M65 levels in identifying early forms of ALD.
Methods
We prospectively evaluated two cohorts of actively drinking patients with alcohol use disorder (AUD) following a rehabilitation program (training ( n = 162) and validation ( n = 78)) and matched healthy controls ( n = 21). Clinical, laboratory, and imaging data were used to distinguish AUD patients with simple steatosis (minimal ALD) and steatohepatitis/fibrosis (early ALD). We measured serum K18‐M65 levels and assessed their ability to predict early ALD.
Results
High levels of K18‐M65 characterized AUD patients with early ALD, while levels in the minimal ALD group were similar to those in healthy controls. K18‐M65 levels distinguished minimal liver disease from early ALD (AUROC = 0.8704; p < 0.0001) with an optimal cutoff at 265.9 U/L. K18‐M65 levels strongly correlated with transaminases and predicted early ALD (OR 25.81; 95% CI 3.166–336.1; p < 0.0001), controlled attenuation parameter, and liver stiffness independently from transaminases and other potential confounders. K18‐M65 levels did not discriminate between fibrosis and steatohepatitis but correlated with histological signs of hepatocellular injury and inflammation (all p < 0.05). The K18‐M65 cutoff detected early ALD in the validation cohort with high accuracy (sensitivity 86.67%, specificity 96.67%) and a very high positive likelihood ratio (28.6; 95% CI 4.14–197.73).
Conclusions
Serum K18‐M65 levels can be used as a biomarker to detect early ALD stages with excellent predictive value.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Hepato-Gastroenterology, Institute of Experimental and Clinical Research, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.
- Department of Hepato-Gastroenterology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
- Department of Medicine, University of California San Diego, La Jolla, California, USA.
- Department of Medicine, VA San Diego Healthcare System, San Diego, California, USA.
ORCID-Profile: Luca Maccioni, Yves Horsmans, Isabelle Leclercq, Bernd Schnabl, Peter Stärkel
Förderung
- NIH HHS
- BLRD VA
- NIDDK NIH HHS
- NIAAA NIH HHS
- Biocodex Microbiota Foundation
- Biomedical Laboratory Research and Development, VA Office of Research and Development
- Fonds De La Recherche Scientifique - FNRS
- Waalse Gewest
Zitieren
APA
Maccioni, L., Horsmans, Y., Leclercq, I., Schnabl, B., & Stärkel, P. (2023). Serum keratin 18‐M65 levels detect progressive forms of alcohol‐associated liver disease in early noncirrhotic stages. Alcohol: Clinical and Experimental Research, 47(6), 1079-1087. https://doi.org/10.1111/acer.15081
Vancouver
Maccioni L, Horsmans Y, Leclercq I, Schnabl B, Stärkel P. Serum keratin 18‐M65 levels detect progressive forms of alcohol‐associated liver disease in early noncirrhotic stages. Alcohol: Clinical and Experimental Research. 2023;47(6):1079-1087. doi:10.1111/acer.15081
BibTeX
@article{Maccioni2023,
author = {Maccioni, Luca and Horsmans, Yves and Leclercq, Isabelle and Schnabl, Bernd and Stärkel, Peter},
title = {Serum keratin 18‐M65 levels detect progressive forms of alcohol‐associated liver disease in early noncirrhotic stages},
journal = {Alcohol: Clinical and Experimental Research},
year = {2023},
volume = {47},
number = {6},
pages = {1079--1087},
doi = {10.1111/acer.15081}
}
EUVIMED